Stem Cell Transplant and Cell Therapy Billing, Coding and Reimbursement Consult

The University of Connecticut Health Center (UConn Health) has issued a Request for Proposal (RFP) seeking a consultative partner to provide comprehensive support for stem cell transplant and cell therapy billing, coding, and reimbursement services. The primary focus of this procurement is to develop and evaluate coding, charging, and billing structures for two specific medical service areas: Bone Marrow Transplant (BMT) services and upcoming Chimeric Antigen Receptor T-cell (CAR-T) therapies, with the CAR-T program anticipated to launch in 2026. The solicitation (UCHC2-195078412) requires a vendor with expertise in healthcare billing and coding infrastructure, capable of providing strategic advisement and comprehensive development of complex medical service billing processes. The proposal period runs from April 9, 2025, to May 7, 2025, with a specific vendor Q&A window scheduled from April 16, 2025, to April 22, 2025. The primary contact for this solicitation is John Russell, who can be reached at 860-679-1775 or jjrussell@uchc.edu, located at 16 Munson Road in Farmington, CT.

The RFP appears to be open to all vendors without specific set-aside designations or restrictions on organizational types. No information is provided about incumbent vendors or existing technology infrastructure that would require integration. The solicitation includes payment terms of Net 45 Days and does not specify an estimated total contract value. The contract will cover professional consulting services to support UConn Health's strategic development of billing and coding processes for advanced medical treatment services, specifically targeting bone marrow transplant and emerging CAR-T cell therapies. While no specific funding sources are detailed in the documentation, the procurement suggests a complex and specialized engagement requiring in-depth knowledge of healthcare billing, coding practices, and emerging medical treatment billing methodologies. Potential respondents should have demonstrable expertise in healthcare financial systems, medical coding standards, and the specific nuanced billing requirements for stem cell and cell therapy services.